{
    "sec_cik": "0000875320",
    "sec_company_name": "VERTEX PHARMACEUTICALS INC / MA (Filer)",
    "document_type": "10K",
    "sec_form_header": "Form 10-K",
    "sec_period_of_report": "20181231",
    "sec_filing_date": "20190213",
    "sec_changed_date": "20190213",
    "sec_accepted_date": "20190213163826",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/875320/000087532019000006/0000875320-19-000006-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/875320/000087532019000006/0000875320-19-000006.txt",
    "metadata_file_name": "/home/koshy/Desktop/Capstone/fintech/data/SEC/batch_0001/003/VRTX_0000875320_10K_20181231_Item7_metadata.json",
    "original_file_name": "",
    "original_file_size": "3088581 chars",
    "document_group": "10-K",
    "section_name": "Item7",
    "section_n_characters": 74028,
    "endpoints": [
        "ITEM 7.MANAGEMENTâ€™S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
        "ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK"
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "VRTX",
    "output_file": "/home/koshy/Desktop/Capstone/fintech/data/SEC/batch_0001/003/VRTX_0000875320_10K_20181231_Item7_excerpt.txt",
    "time_elapsed": 0.7,
    "batch_number": 1,
    "batch_signature": "",
    "batch_start_time": "2020-01-15 02:06:11.586534",
    "batch_machine_id": "koshy-Legion",
    "section_end_time": "2020-01-15 02:28:46.000913"
}